Sanitation enzymes: Exquisite surveillance of the noncanonical nucleotide pool to safeguard the genetic blueprint.


Journal

Seminars in cancer biology
ISSN: 1096-3650
Titre abrégé: Semin Cancer Biol
Pays: England
ID NLM: 9010218

Informations de publication

Date de publication:
09 2023
Historique:
received: 03 02 2023
revised: 14 05 2023
accepted: 17 05 2023
medline: 12 7 2023
pubmed: 22 5 2023
entrez: 21 5 2023
Statut: ppublish

Résumé

Reactive oxygen species (ROS) are common products of normal cellular metabolism, but their elevated levels can result in nucleotide modifications. These modified or noncanonical nucleotides often integrate into nascent DNA during replication, causing lesions that trigger DNA repair mechanisms such as the mismatch repair machinery and base excision repair. Four superfamilies of sanitization enzymes can effectively hydrolyze noncanonical nucleotides from the precursor pool and eliminate their unintended incorporation into DNA. Notably, we focus on the representative MTH1 NUDIX hydrolase, whose enzymatic activity is ostensibly nonessential under normal physiological conditions. Yet, the sanitization attributes of MTH1 are more prevalent when ROS levels are abnormally high in cancer cells, rendering MTH1 an interesting target for developing anticancer treatments. We discuss multiple MTH1 inhibitory strategies that have emerged in recent years, and the potential of NUDIX hydrolases as plausible targets for the development of anticancer therapeutics.

Identifiants

pubmed: 37211293
pii: S1044-579X(23)00079-2
doi: 10.1016/j.semcancer.2023.05.005
pii:
doi:

Substances chimiques

Nucleotides 0
Phosphoric Monoester Hydrolases EC 3.1.3.2
DNA Repair Enzymes EC 6.5.1.-
Reactive Oxygen Species 0
DNA 9007-49-2

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-20

Subventions

Organisme : CIHR
ID : FDN-154318
Pays : Canada

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflicts of interest.

Auteurs

Kirsten Broderick (K)

Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.

Mohamed Taha Moutaoufik (MT)

Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.

Khaled A Aly (KA)

Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.

Mohan Babu (M)

Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada. Electronic address: mohan.babu@uregina.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH